Aashka Hospitals Ltd.
Snapshot View

42.05 -0.40 ▼-0.9%

24 May 2022, 04:01:00 PM
Volume: 39,000

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.aashkahospitals.in
Market Cap 98.63 Cr.
Enterprise Value(EV) 123.34 Cr. 2021-03
Financial Indicators
Earnings per share (EPS) 1.76 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 23.98 Trailing Twelve Months Ending 2021-03
Industry PE 40.42 Trailing Twelve Months Ending 2021-03
Book Value / Share 54.65 Trailing Twelve Months Ending 2021-03
Price to Book Value 0.77 Calculated using Price: 42.15
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 2.34 Cr. 23,400,000 Shares
FaceValue 10
Company Profile

The company is certified by National Accreditation Board for Hospitals and Healthcare Providers (NABH Accredited) for tertiary and apical care level hospital in Gujarat. It is an integrated healthcare service provider, committed to deliver quality healthcare services to its patients in modern facilities that includes prevention, best treatment and proper rehabilitation. The company decided to step-up its support in the fight against COVID-19 and was a designated COVID-19 treatment hospital. With the support of its doctors and staffs, it has treated more than 2000 COVID-19 patients. The company is a growing organization that aims at strengthening and establishing itself as the foremost healthcare services provider. It strives to serve with its ultra-modern medicinal practices and state of the art infrastructure for medical as well as surgical care solutions.

The company has a team of medical practitioners who ensures that patients get the quality healthcare services. Its dedicated team is trained to take care of the patients and handle all kinds of emergencies. Its healthcare staff members comprise of Medical Director, Quality Manager, Clinical pharmacist, Microbiologist, Medical Officers, Clinical Assistants, Infection Control Nurse, Nursing staff, Attendants, Technicians, Dietician/Nutritionist, Medical Transcriber, Biomedical Engineers. It is associated with Companies, Organization, University and Institute for providing regular healthcare check-up facilities to their employees and their Post-Graduation Students at affordable rates. It has entered into Memorandum of Understanding with Blood Banks like Shraddhadeep Blood Bank and Sanjivani Blood Bank (Vol.) and Apheresis Centre from whom it procure blood and blood components to the meet the needs of patients admitted at its hospital. Also, it has associations and affiliations with major Insurance Companies that processes insurance claims admissible under the Mediclaim policy for its patients.

Business area of the company

Aashka Hospital is an integrated healthcare service provider that offers the best quality of healthcare facilities including prevention, best treatment, and rehabilitation.

Awards, Accreditations or Recognition

  • 2019: The company has issued a certificate of accreditation by NABH for being compliant with NABH pre-accreditation entry level hospital requirements.
  • 2021: Received certificate of appreciation for hardwork and appreciation from Dr. Justice Ashokkumar Joshi (Judge High Court of Gujarat Sola, Ahmedabad).

Major Events

  • 2012: Incorporation of Company as a private company in the name of ‘Aashka Hospitals Private Limited’.
  • 2018: Conversion of Private Company to Public Company in the name and style of ‘Aashka Hospitals Limited’.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-0.94%
1 Week
-1.75%
1 Month
-17.87%
3 Month
-7.58%
6 Month
-6.24%
1 Year
2 Year
5 Year
10 Year
3 years 2019-03 2020-03 2021-03
Return on Equity (%) 8.87 6.97 15.40
Return on Capital Employed (%) 14.54 11.72 13.03
Return on Assets (%) 2.52 2.42 6.58

Balance Sheet View Details

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Shh. Funds 15 24 29
Non Curr. Liab. 26 26 21
Curr. Liab. 13 10 15
Minority Int.
Equity & Liab. 54 60 65
Non Curr. Assets 47 44 50
Curr. Assets 7 16 15
Misc. Exp. not W/O
Total Assets 54 60 65

Profit Loss View Details

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Net Sales 28 27 41
Other Income 0 0
Total Income 28 27 41
Total Expenditure -18 -19 -31
PBIDT 10 9 10
Interest -6 -5 -3
Depreciation -3 -3 -3
Taxation
Exceptional Items
PAT 1 1 4
Adjusted EPS 1 1 2

Cash Flow View Details

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 10 -1 15
Cash Fr. Inv. 0 0 -8
Cash Fr. Finan. -9 4 -8
Net Change 1 3 -1
Cash & Cash Eqvt 1 4 3

Shareholding Pattern View Details

2 Qtrs 2021-09 (%) 2022-03 (%)
Promoter 61.28 61.28
Public 38.72 38.72
Depository Receipts 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00

Announcements View Details

Sat, 14 May 2022
Compliances-Reg.24(A)-Annual Secretarial Compliance
Non- applicability of regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) regulations 2015 (SEBI Listing regulations).
Fri, 13 May 2022
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company Aashka Hospitals Ltd
2 CIN NO. U85110GJ2012PLC072647
3 Report filed for FY 2021-2022
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* FY 2021-22 2022-23
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) NA
8Quantum of (d) which has been met from (c)(e)* NA
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* NA


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)FY 2021-22 2022-23
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-Bhavesh N Sonesara
Designation :-Company Secretary
Name of the Chief Financial Officer :- Bhavesh Sonesara resigned with effect from twenty eight march two thousand twenty two
Designation : -Chief financial officer

Date: 13/05/2022

Tue, 03 May 2022
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Disclosure under Regulation 30 of the SEBI (LODR) Regulations 2015- Resignation of Company Secretary & Compliance Officer.

Technical Scans View Details

Tue, 24 May 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,371.20 914.30 -0.8%
Divi's Laboratories Ltd. 97,215.92 3,662.05 -6.0%
Cipla Ltd. 78,341.65 970.95 +0.0%
Dr. Reddy's Laboratories Ltd. 72,413.55 4,351.10 +1.8%
Apollo Hospitals Enterprise Ltd. 52,337.62 3,640.00 -2.2%
Gland Pharma Ltd. 47,375.00 2,878.60 -3.4%
Torrent Pharmaceuticals Ltd. 44,015.42 2,601.25 -0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-12 34.04 914.30 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 32.84 3,662.05 -6.0%
Cipla Ltd. Consolidated 2022-03 31.13 970.95 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 33.18 4,351.10 +1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-12 46.18 3,640.00 -2.2%
Gland Pharma Ltd. Consolidated 2022-03 39.10 2,878.60 -3.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-12 36.11 2,601.25 -0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-12 4.25 914.30 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8.29 3,662.05 -6.0%
Cipla Ltd. Consolidated 2022-03 3.76 970.95 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.77 4,351.10 +1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-12 9.46 3,640.00 -2.2%
Gland Pharma Ltd. Consolidated 2022-03 6.62 2,878.60 -3.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-12 6.81 2,601.25 -0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 914.30 -0.8%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,662.05 -6.0%
Cipla Ltd. Consolidated 2021-03 0.10 970.95 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,351.10 +1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,640.00 -2.2%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,878.60 -3.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,601.25 -0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 914.30 -0.8%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,662.05 -6.0%
Cipla Ltd. Consolidated 2021-03 14.13 970.95 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,351.10 +1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,640.00 -2.2%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,878.60 -3.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,601.25 -0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 914.30 -0.8%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,662.05 -6.0%
Cipla Ltd. Consolidated 2021-03 14.13 970.95 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,351.10 +1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,640.00 -2.2%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,878.60 -3.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,601.25 -0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 914.30 -0.8%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,662.05 -6.0%
Cipla Ltd. Consolidated 2021-03 19,159.59 970.95 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,351.10 +1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,640.00 -2.2%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,878.60 -3.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,601.25 -0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 914.30 -0.8%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,662.05 -6.0%
Cipla Ltd. Consolidated 2021-03 2,401.30 970.95 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,351.10 +1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,640.00 -2.2%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,878.60 -3.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,601.25 -0.6%